- Home
- MNPR vs LSF Comparison
MNPR vs LSF Comparison
Compare MNPR & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- LSF
- Stock Information
- Founded
- MNPR 2014
- LSF 2015
- Country
- MNPR United States
- LSF United States
- Employees
- MNPR N/A
- LSF N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- LSF Packaged Foods
- Sector
- MNPR Health Care
- LSF Consumer Staples
- Exchange
- MNPR Nasdaq
- LSF Nasdaq
- Market Cap
- MNPR 95.5M
- LSF 90.1M
- IPO Year
- MNPR 2019
- LSF 2020
- Fundamental
- Price
- MNPR $18.09
- LSF $8.56
- Analyst Decision
- MNPR Strong Buy
- LSF Strong Buy
- Analyst Count
- MNPR 3
- LSF 2
- Target Price
- MNPR $27.33
- LSF $7.75
- AVG Volume (30 Days)
- MNPR 1.5M
- LSF 163.5K
- Earning Date
- MNPR 11-08-2024
- LSF 11-06-2024
- Dividend Yield
- MNPR N/A
- LSF N/A
- EPS Growth
- MNPR N/A
- LSF N/A
- EPS
- MNPR N/A
- LSF N/A
- Revenue
- MNPR N/A
- LSF $40,896,326.00
- Revenue This Year
- MNPR N/A
- LSF $21.72
- Revenue Next Year
- MNPR N/A
- LSF $10.16
- P/E Ratio
- MNPR N/A
- LSF N/A
- Revenue Growth
- MNPR N/A
- LSF 20.33
- 52 Week Low
- MNPR $1.37
- LSF $0.71
- 52 Week High
- MNPR $38.50
- LSF $10.35
- Technical
- Relative Strength Index (RSI)
- MNPR 60.19
- LSF 61.10
- Support Level
- MNPR $16.26
- LSF $8.16
- Resistance Level
- MNPR $19.70
- LSF $10.35
- Average True Range (ATR)
- MNPR 2.15
- LSF 0.91
- MACD
- MNPR -0.07
- LSF 0.03
- Stochastic Oscillator
- MNPR 74.36
- LSF 48.57
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.